{"id":24166,"date":"2026-09-10T15:04:58","date_gmt":"2026-09-10T13:04:58","guid":{"rendered":"https:\/\/elainternational.eu\/?post_type=news&#038;p=24166"},"modified":"2026-09-10T15:08:15","modified_gmt":"2026-09-10T13:08:15","slug":"zanvastro-alexander","status":"publish","type":"news","link":"https:\/\/elainternational.eu\/en\/actualites\/zanvastro-alexander\/","title":{"rendered":"The first-ever\u00a0treatment for Alexander disease approved in the USA"},"content":{"rendered":"\n\n<div class=\"block-wrapper\">\n    <div class=\"container-content\">\n        <h3>The first-ever\u00a0treatment for Alexander disease approved in the USA<\/h3>\n<p>Zilganersen (Zanvastro\u2122)\u00a0is the first\u00a0treatment for Alexander disease (AxD) for both adults and children. This leukodystrophy\u00a0affects approximately\u00a01 in\u00a03\u00a0million children (Japanese estimate).<\/p>\n<p>When the disease manifests, it attacks the myelin, the protective sheath surrounding the nervous system. Symptoms can\u00a0sometime\u00a0develop rapidly: cognitive impairment, epilepsy, motor impairment, and neurological\u00a0symptoms that appear\u00a0almost\u00a0overnight\u2026<\/p>\n<p>This approval by the Federal Drug Administration (FDA) in the US marks a crucial milestone for patients and their families. ELA International is now focused on making this treatment more widely available across Europe as soon as possible.<\/p>\n\n            <\/div>\n<\/div>\n\n\n\n\n\n    <style>\n        .single-image {\n            margin-bottom: 30px;\n        }\n\n        .heading4 {\n            margin-bottom: 30px;\n            font-size: 25px;\n            line-height: 27.5px;\n        }\n    <\/style>\n\n    <div class=\"container-content\">\n        <div class=\"single-image\" style=\"\">\n            <img decoding=\"async\" src=\"https:\/\/elainternational.eu\/wp-content\/uploads\/2026\/09\/Miniature-1-colonne-Sofiene.jpg\" alt=\"\">\n        <\/div>\n        <h3 class=\"heading4\" style=\"\"><\/h3>\n    <\/div>\n\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":6,"featured_media":20591,"parent":0,"template":"","news_categories":[97],"class_list":["post-24166","news","type-news","status-publish","has-post-thumbnail","hentry","news_categories-international-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The first-ever\u00a0treatment for Alexander disease approved in the USA - ELA International<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/elainternational.eu\/en\/actualites\/zanvastro-alexander\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The first-ever\u00a0treatment for Alexander disease approved in the USA - ELA International\" \/>\n<meta property=\"og:url\" content=\"https:\/\/elainternational.eu\/en\/actualites\/zanvastro-alexander\/\" \/>\n<meta property=\"og:site_name\" content=\"ELA International\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-10T13:08:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/elainternational.eu\/wp-content\/uploads\/2024\/07\/entete_recherche-C-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"534\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/actualites\\\/zanvastro-alexander\\\/\",\"url\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/actualites\\\/zanvastro-alexander\\\/\",\"name\":\"The first-ever\u00a0treatment for Alexander disease approved in the USA - ELA International\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/actualites\\\/zanvastro-alexander\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/actualites\\\/zanvastro-alexander\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/elainternational.eu\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/entete_recherche-C-scaled.jpg\",\"datePublished\":\"2026-09-10T13:04:58+00:00\",\"dateModified\":\"2026-09-10T13:08:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/actualites\\\/zanvastro-alexander\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/elainternational.eu\\\/en\\\/actualites\\\/zanvastro-alexander\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/actualites\\\/zanvastro-alexander\\\/#primaryimage\",\"url\":\"https:\\\/\\\/elainternational.eu\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/entete_recherche-C-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/elainternational.eu\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/entete_recherche-C-scaled.jpg\",\"width\":2560,\"height\":534},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/actualites\\\/zanvastro-alexander\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The first-ever\u00a0treatment for Alexander disease approved in the USA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/\",\"name\":\"ELA International\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/elainternational.eu\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The first-ever\u00a0treatment for Alexander disease approved in the USA - ELA International","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/elainternational.eu\/en\/actualites\/zanvastro-alexander\/","og_locale":"en_US","og_type":"article","og_title":"The first-ever\u00a0treatment for Alexander disease approved in the USA - ELA International","og_url":"https:\/\/elainternational.eu\/en\/actualites\/zanvastro-alexander\/","og_site_name":"ELA International","article_modified_time":"2026-09-10T13:08:15+00:00","og_image":[{"width":2560,"height":534,"url":"https:\/\/elainternational.eu\/wp-content\/uploads\/2024\/07\/entete_recherche-C-scaled.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/elainternational.eu\/en\/actualites\/zanvastro-alexander\/","url":"https:\/\/elainternational.eu\/en\/actualites\/zanvastro-alexander\/","name":"The first-ever\u00a0treatment for Alexander disease approved in the USA - ELA International","isPartOf":{"@id":"https:\/\/elainternational.eu\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/elainternational.eu\/en\/actualites\/zanvastro-alexander\/#primaryimage"},"image":{"@id":"https:\/\/elainternational.eu\/en\/actualites\/zanvastro-alexander\/#primaryimage"},"thumbnailUrl":"https:\/\/elainternational.eu\/wp-content\/uploads\/2024\/07\/entete_recherche-C-scaled.jpg","datePublished":"2026-09-10T13:04:58+00:00","dateModified":"2026-09-10T13:08:15+00:00","breadcrumb":{"@id":"https:\/\/elainternational.eu\/en\/actualites\/zanvastro-alexander\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/elainternational.eu\/en\/actualites\/zanvastro-alexander\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/elainternational.eu\/en\/actualites\/zanvastro-alexander\/#primaryimage","url":"https:\/\/elainternational.eu\/wp-content\/uploads\/2024\/07\/entete_recherche-C-scaled.jpg","contentUrl":"https:\/\/elainternational.eu\/wp-content\/uploads\/2024\/07\/entete_recherche-C-scaled.jpg","width":2560,"height":534},{"@type":"BreadcrumbList","@id":"https:\/\/elainternational.eu\/en\/actualites\/zanvastro-alexander\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/elainternational.eu\/en\/"},{"@type":"ListItem","position":2,"name":"The first-ever\u00a0treatment for Alexander disease approved in the USA"}]},{"@type":"WebSite","@id":"https:\/\/elainternational.eu\/en\/#website","url":"https:\/\/elainternational.eu\/en\/","name":"ELA International","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/elainternational.eu\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/elainternational.eu\/en\/wp-json\/wp\/v2\/news\/24166","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/elainternational.eu\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/elainternational.eu\/en\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/elainternational.eu\/en\/wp-json\/wp\/v2\/users\/6"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/elainternational.eu\/en\/wp-json\/wp\/v2\/media\/20591"}],"wp:attachment":[{"href":"https:\/\/elainternational.eu\/en\/wp-json\/wp\/v2\/media?parent=24166"}],"wp:term":[{"taxonomy":"news_categories","embeddable":true,"href":"https:\/\/elainternational.eu\/en\/wp-json\/wp\/v2\/news_categories?post=24166"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}